{"id":"de029072-9fe3-5d91-85c4-e5282f74179a","stable_key":"6b15b2de-9ce9-5b6f-ab8b-3c7dbb4c15c7:stevia-rebd-liver","predicate":"reduces","statement":"Rebaudioside D at 50 mg/kg orally for 12 weeks reduced hepatic triglycerides, cholesterol and lipid peroxidation in male high-fat/high-sucrose-fed mice.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"fb823259-810e-5c24-b9f3-8cdb2cbe762e","mechanism_event_label":"A less common glycoside had a liver phenotype in an obesity model.","subject":{"id":"f6c3869b-5049-52d8-b31d-98bfd421ebf4","slug":"rebaudioside-d","display_name":"Rebaudioside D","entity_type_key":"small_molecule"},"object":{"id":"3a769775-50cf-5483-b0ca-25e87ef05df3","slug":"mouse-rebd-hepatic-lipid-accumulation","display_name":"Mouse rebaudioside-D hepatic lipid accumulation","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"fb823259-810e-5c24-b9f3-8cdb2cbe762e","stable_key":"6b15b2de-9ce9-5b6f-ab8b-3c7dbb4c15c7:stevia-rebd-liver-event","event_type":"observed_relationship","label":"A less common glycoside had a liver phenotype in an obesity model.","description":"Rebaudioside D at 50 mg/kg orally for 12 weeks reduced hepatic triglycerides, cholesterol and lipid peroxidation in male high-fat/high-sucrose-fed mice.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"f6c3869b-5049-52d8-b31d-98bfd421ebf4","slug":"rebaudioside-d","display_name":"Rebaudioside D","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"3a769775-50cf-5483-b0ca-25e87ef05df3","slug":"mouse-rebd-hepatic-lipid-accumulation","display_name":"Mouse rebaudioside-D hepatic lipid accumulation","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"c78086c3-7657-589b-b353-1691df2d9f8f","slug":"stevia","display_name":"Stevia","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"d3a1b93d-0a2c-5d1b-b672-5e4ef4b09a10","slug":"cholesterol","display_name":"Cholesterol","entity_type_key":"lipid"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Male C57BL/6J diet-induced obesity; rebaudioside A and vehicle comparators.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Mouse dosing is not ordinary human food exposure; lower lipid content does not identify a unique molecular target.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Stevia collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"stevia","display_name":"Stevia","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"A less common glycoside had a liver phenotype in an obesity model.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Rebaudioside D decreases adiposity and hepatic lipid accumulation in a mouse model of obesity. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38321177/ · DOI 10.1038/s41598-024-53587-y","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"8528535a-310c-549e-aff3-d47d1dd4c91b","evidence_kind":"source_excerpt","locator":"Lines 418-424","start_line":418,"end_line":424,"excerpt":"## stevia-rebd-liver\nA less common glycoside had a liver phenotype in an obesity model.\nRebaudioside D at 50 mg/kg orally for 12 weeks reduced hepatic triglycerides, cholesterol and lipid peroxidation in male high-fat/high-sucrose-fed mice.\nModel: Male C57BL/6J diet-induced obesity; rebaudioside A and vehicle comparators.\nLimitations: Mouse dosing is not ordinary human food exposure; lower lipid content does not identify a unique molecular target.\nEvidence access: Primary abstract\nRebaudioside D decreases adiposity and hepatic lipid accumulation in a mouse model of obesity. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38321177/ · DOI 10.1038/s41598-024-53587-y","model_system":"Male C57BL/6J diet-induced obesity; rebaudioside A and vehicle comparators.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"295304c9-609c-5b05-a18f-a00ab7b965ed","stable_key":"import-6b15b2de-9ce9-5b6f-ab8b-3c7dbb4c15c7","title":"Stevia: glycoside metabolism, taste, ion channels and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"a36a82c2f8a0a971ea43e9e742db65f45848d13ab77310c0dd6b5cd55e31fc16","revision_id":"ea0355af-a926-511a-a7f2-1750baa95a8d","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}